Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03924505 · ClinicalTrials.gov registry record · NA
Preventing Opioid Overdose Mortality in the United States
A NA study, sponsored by RTI International.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT03924505: Completed NA study, sponsored by RTI International.
NCT03924505 is a NA study that has completed, run by RTI International. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03924505, a NA study, has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study aims to conduct a randomized controlled trial of 105 syringe services programs (SSPs) throughout the United States to understand the effectiveness of a multifaceted, facilitation-based strategy at advancing naloxone implementation effectiveness within SSPs. Together, these efforts can improve access to naloxone for people at high risk of overdose, thereby improving our nation's response to the opioid overdose epidemic.
Primary Outcome
Mean number of syringe services program participants receiving naloxone per total number of syringe services program participants
Interventions
- OTHER Organize and Mobilize for Implementation Effectiveness
- OTHER Dissemination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2022-03-14 |
| Phase | NA |
What the finished NCT03924505 record still lists
NCT03924505 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Organize and Mobilize for Implementation Effectiveness is the first listed.
NCT03924505 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03924505 about?
NCT03924505 is a clinical study titled "Preventing Opioid Overdose Mortality in the United States". This study aims to conduct a randomized controlled trial of 105 syringe services programs (SSPs) throughout the United States to understand the effectiveness of a multifaceted, facilitation-based strategy at advancing naloxone implementation effectiveness within SSPs. Together, these efforts can imp...
What is the current status of trial NCT03924505?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2019-09-03. Estimated completion is 2022-03-14.
What interventions are being tested in trial NCT03924505?
The interventions under investigation include: Organize and Mobilize for Implementation Effectiveness (OTHER), Dissemination (OTHER).
Who is sponsoring clinical trial NCT03924505?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03924505's enrollment target sits among peer trials
105 834th of 2000 higher than 1,165 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI